Mainit, Arnold L.

HRN: 25-16-83  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
CEFTAZIDIME 1GM (VIAL)
05/30/2024
06/13/2024
IV
2g
Every 8 Hours
Infected Wound, Right Foot
Waiting Final Action 
05/30/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2024
06/06/2024
IV
600mg
Every 8 Hours
Infected Wound, Right Foot
Waiting Final Action 
06/02/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/02/2024
06/08/2024
TOPICAL
25g
BID
SEPSIS SEC. TO NIFU SEC. TO PAOD VS DM TYPE II
Waiting Final Action 
06/07/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/07/2024
06/13/2024
IVT
600mg
Q6
Sepsis Sec To NIFU Sec To PAOD Vs DM Type II
Waiting Final Action 
06/17/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/17/2024
06/23/2024
TOPICAL
Apply Thin Coat
BID
Soft Tissue Infection
Waiting Final Action 
06/17/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/17/2024
06/24/2024
TOPICAL
Apply Directly
Every 12 Hours
NIFU
Waiting Final Action 
06/29/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/24/2024
07/01/2024
TOPICAL
Apply Thin Coat
BID
Wound Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: